November 12, 2020Open Access

microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Taken together, miR-96 antagomir could potentially retard the cancerogenesis in CRC via AMPKα2-dependent inhibition of FTO and blocking FTO-mediated m6A modification of MYC, highlighting novel mechanisms associated with colorectal cancerogenesis.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Yue et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd43bc7808b00a4799bdbf https://doi.org/https://doi.org/10.1186/s13046-020-01731-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Low expression of microRNA-1266 promotes colorectal cancer progression via targeting FTO.2018 · 39 citations
2RT-qPCR for Fecal Mature MicroRNA Quantification and Validation2018 · 18 citations
3A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer2019 · 121 citations
4Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation2018 · 33 citations
5miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae12019 · 53 citations

Me gusta

Guardar

Ver artículo completo